Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

Lasers and light treatments are now the most common ways to remove hair.

Niosomes are the most effective at delivering drugs to the skin with minimal absorption into the body.

The congress concluded that misuse of antifungal drugs in South Asia has led to widespread treatment failure, and new approaches and regional cooperation are needed.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

A new green method accurately measures finasteride and tadalafil in drugs and plasma.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Cosmeceuticals may have potential but their effectiveness and market success are still uncertain.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Ethosomes are a promising method for treating hair loss by delivering drugs directly to the scalp.

New treatments for hair loss include low-dose pills, updated drugs, supplements, light therapy, plasma injections, and advanced hair transplant techniques.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

The document concludes that current hair loss treatments have limitations and suggests researching new treatments targeting different factors of hair loss.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Haloperidol effectively treated hemiballismus, but spontaneous improvement wasn't ruled out; rapid weight loss can cause hair loss with good regrowth chances.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Bimatoprost is safe and effective for improving eyebrow hair.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Active transdermal technologies in cosmetics help deliver skin treatments effectively, but their safety and effectiveness depend on skin type and treatment choice.

Animal models are crucial for learning about hair loss and finding treatments.

New treatments for male hair loss show promise but need more research for safety and effectiveness.

A man developed a serious muscle breakdown condition after using a hair loss medication not known to cause this side effect.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.